Atyr’s Covid-19 benefit claims raise questions
The group has blamed placebo “overperformance” on a high proportion of less-sick patients.
Clinical developments over the Christmas period
Trial results in Covid-19 and cancer emerge, but little promise is seen.
Europe backs Pfizer/Biontech Covid-19 vaccine's broad applicability
An extraordinary meeting of the EU CHMP recommends conditional approval of Pfizer/Biontech’s Covid-19 vaccine.
A new setting for antigen testing
It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.
Incyte’s Jakafi disappoints in severe Covid-19
As Jak inhibition takes a big knock, attention turns to other immunosuppressive mechanisms being studied in very ill Covid-19 patients.
Atyr’s Covid-19 benefit claims raise questions
The group has blamed placebo “overperformance” on a high proportion of less-sick patients.
Clinical developments over the Christmas period
Trial results in Covid-19 and cancer emerge, but little promise is seen.
Europe backs Pfizer/Biontech Covid-19 vaccine's broad applicability
An extraordinary meeting of the EU CHMP recommends conditional approval of Pfizer/Biontech’s Covid-19 vaccine.
A new setting for antigen testing
It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.
Incyte’s Jakafi disappoints in severe Covid-19
As Jak inhibition takes a big knock, attention turns to other immunosuppressive mechanisms being studied in very ill Covid-19 patients.
